Skip to main content
See every side of every news story
Published • loading... • Updated

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback

The withdrawal leaves the Food and Drug Administration without a permanent nominee as the White House seeks a new direction and support for Kennedy’s agenda.

  • On Tuesday, The White House withdrew Heidi Overton's nomination to lead the Food and Drug Administration after determining she lacked sufficient Senate support.
  • Her nomination faced bipartisan resistance in Congress, alongside criticism from Antiabortion forces and supporters of Health Secretary Robert Kennedy's Make America Healthy Again movement.
  • Previously expressing "strong concerns," Republican Sen. Bill Cassidy of Louisiana, chairman of the Senate Health and Pensions Committee, called Overton's role "almost disqualifying."
  • Officials stated the White House intends to "go in a new direction at FDA" while continuing to support Kennedy's health agenda, necessitating a new candidate search.
  • Since Marty Makary's resignation in May, the agency has operated under acting Commissioner Kyle Diamantas, leaving the administration to identify a replacement to lead the FDA.
Insights by Ground AI

23 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 78% of the sources are Center
78% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Winnipeg Free Press broke the news in Winnipeg, Canada on Tuesday, November 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal